Not every peptide in your knee is on your side. In a Nov 17 Heidelberg lab study, CGRP, a migraine pain peptide, stopped human lab cartilage from rebuilding after a walking-style squeeze. Lab only, not people. Quieting pain and fixing a joint are two jobs. https://t.co/FEruQFfWqp
One cord-blood stem cell shot cut knee arthritis pain by over half in a 113-person trial. Placebo cut it 23%. The cartilage MRI score barely moved: +2.7 points. Big relief, repair still a maybe. Investigational, sponsor-run. https://t.co/7iWFAxhhpp
Hurt your knee, and the MRI shows a hole in the cartilage down to the bone. A pain pill can quiet it. It can't fill it.
New small RCT (Zhu et al., Med Sci Monit, Nov 2026): 36 adults with knee cartilage defects got either microfracture (holes poked in the bone so marrow forms scar-like fibrocartilage) or a type I collagen scaffold pressed into the defect.
At 12 months the collagen group scored better on function (Lysholm 91.9 vs 82.9) and, more interesting to me, on the MRI cartilage repair score (MOCART 84.5 vs 70.6), the main endpoint. That's a structural measure of the tissue on top of a symptom score.
Fine print: one hospital, one year, no power calculation, surgeons not blinded, no human biopsies, and the authors say they can't rule out the scaffold just filling the hole. This is surgery, not collagen powder.
Ask your surgeon what treats your pain and what treats the hole. Study: https://t.co/bCVpJ9CDE0
Would you pick the decades-old surgery or the newer scaffold with better one-year scans?
Hurt your knee, and the MRI shows a hole in the cartilage down to the bone. A pain pill can quiet it. It can't fill it.
New small RCT (Zhu et al., Med Sci Monit, Nov 2026): 36 adults with knee cartilage defects got either microfracture (holes poked in the bone so marrow forms scar-like fibrocartilage) or a type I collagen scaffold pressed into the defect.
At 12 months the collagen group scored better on function (Lysholm 91.9 vs 82.9) and, more interesting to me, on the MRI cartilage repair score (MOCART 84.5 vs 70.6), the main endpoint. That's a structural measure of the tissue on top of a symptom score.
Fine print: one hospital, one year, no power calculation, surgeons not blinded, no human biopsies, and the authors say they can't rule out the scaffold just filling the hole. This is surgery, not collagen powder.
Ask your surgeon what treats your pain and what treats the hole. Study: https://t.co/bCVpJ9CDE0
Would you pick the decades-old surgery or the newer scaffold with better one-year scans?
That third candidate on your ballot with no money and slick TV ads? Somebody paid for that. Per Axios, super PACs spent $16.5M+ boosting third-party candidates in close races.
Would you vote differently if you knew who was paying for the third candidate's ads? #Elections#CNN
Yesterday my 3-year-old ran to the door yelling "Happy Veterans Day!" My 1-year-old yelled it too, in his own way. It brought me to tears. This is my day 1 enlistment photo If you served, do you still have yours? #VeteransDay#Army#Navy#AirForce#Marines#CoastGuard#SpaceForce
At 70, with diabetes, he could see his Achilles tendon through a foot wound. 6 months after placenta stem cell shots, it closed. All 10 in this tiny trial healed. 9 got feeling back. No control group, not FDA approved. Check feet daily, see a podiatrist. https://t.co/wUHyN8TiLe
Your mom finishes 2 years of bone-building shots. Then 3 months slip by before the next drug starts. New JBMR data on 8,893 patients: that 90+ day gap was linked to 19% to 31% higher hip fracture risk. Ask the doctor what's next and when. https://t.co/TGyL0h5PgO
@JohnCleese@JohnCleese , you have been part of the problem for years. 1. What has made you change? 2. Why do you still speak against those who you agree with.
Collagen got a GLP-1 study: 10 g before a carb meal raised GLP-1 and cut the glucose rise vs placebo in 30 adults. Fine print: one meal, maker-funded, no whey comparison, and per an industry summary not significant in the prediabetes group alone.
#Collagen#GLP1
New AJSM trial, 240 patients with early knee OA: all got PRP, but a standardized pathway (leukocyte-poor PRP, ultrasound guidance, staged rehab, follow-up) beat usual PRP care at 12 months. Adverse events 14.8% vs 31.9%. No placebo group, so it can't show PRP works.
#PRP
HHS's interim peptide policy covers six peptides, but only one active ingredient per product. By its wording, BPC-157 plus TB-500 in one vial would not qualify.
Routes are limited too. Comments close Nov 13.
#Peptides
Keratoconus trial: donor cornea sheet vs the same sheet plus the patient's own stem cells. 10 eyes, randomized. 12-month thickness gain: +118.4 vs +121.2 microns, so the cells didn't move it. Small, early, investigational.
https://t.co/UYnkj2HGoP
#StemCells#Keratoconus
#Florida's 2020 ghost candidate flipped a state Senate seat by 32 votes. People got caught. RCV doesn't fix that. It just counts around it, and #Alaska's two Sullivans show it may leave MORE room for it. Count around the cheating, or close the holes? #RCV#ElectionIntegrity
FDA's 2019 proposal to add 5 substances to the 503A bulks list still has no final rule (FDA, May 2026). HHS's 6-peptide policy went from filing to Federal Register in 2 days.
Its adverse event reporting is a policy condition, not a statute. Comments close Nov 13.
#Peptides
@grok@WONGthink So this man very literally asked for the result.
@JohnCleese , yes, the soft on crime (unless itβs to arrest people calling for help) politics of policing is terrible there. But this guy is part of the problem. Not the solution.
Even dogs get the placebo effect. Their owners supply it.
Double-blind trial (Vet J, Oct 2026): 45 arthritic dogs, collagen diet vs placebo diet, 12 wks. No difference on owner surveys or force plate gait. Both groups "improved" per owners.
Small, industry funded, not advice.